Rare diseases bullet 3: Wegener's granulomatosis
Open Access
- 1 July 1999
- Vol. 54 (7) , 629-637
- https://doi.org/10.1136/thx.54.7.629
Abstract
The prevalence of WG in the United States has been estimated to be at least three per 100 000 with a male to female ratio of about 1:1. Most patients (80–97%) are Caucasian, whereas African-Americans comprise about 2–8% of most cohorts. The mean age at diagnosis is about 40–55 years, although individuals of any age may be affected.1 Whether there is significant variation in onset of disease with different seasons or precipitation of illness by inhalation of certain particulate or gaseous materials or infection remains a matter of controversy. Recent studies have not supported the notion of seasonal variation whether the data be derived from patient perceptions of disease onset, medical records, or national hospital discharge surveys.1 , 2Keywords
This publication has 64 references indexed in Scilit:
- Interferon γ Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great VesselsThe Journal of Experimental Medicine, 1998
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisNew England Journal of Medicine, 1996
- Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3Clinical and Experimental Immunology, 1995
- Antimyeloperoxidase Antibodies Induce Neutrophil Adherence to Cultured Human Endothelial CellsRenal Failure, 1995
- Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cellsClinical and Experimental Immunology, 1994
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitisClinical and Experimental Immunology, 1990
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisNew England Journal of Medicine, 1988
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985
- Wegener's Granulomatosis: Observations on Treatment With Antimicrobial AgentsMayo Clinic Proceedings, 1985